Funded Tech Companies

Synchroneuron

Looking for the VC firms that provided funding to Synchroneuron? Morningside Group joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
Synchroneuron
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
1188 Centre St.
Newton, MA 02466
USA
Email Address

Company Background Information

Overview
Synchroneuron Inc., a Waltham, Mass.-based biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders.
Profile
Synchroneuron LinkedIn Company Profile
Social Media
Synchroneuron Company Twitter Account
Company News
Synchroneuron News
Facebook
Synchroneuron on Facebook
YouTube
Synchroneuron on YouTube
Last Transaction
7/2/2014

Financing History

Date
Type
Amount
Venture Equity
$20,000,000
Venture Equity
$6,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
William Kerns
  William Kerns LinkedIn Profile  William Kerns Twitter Account  William Kerns News  William Kerns on Facebook
Chief Financial Officer
Marc Cote
  Marc Cote LinkedIn Profile  Marc Cote Twitter Account  Marc Cote News  Marc Cote on Facebook
Chief Scientific Officer
Barry Fogel
  Barry Fogel LinkedIn Profile  Barry Fogel Twitter Account  Barry Fogel News  Barry Fogel on Facebook
VP - Bus. Development
Kei-Lai Fong
  Kei-Lai Fong LinkedIn Profile  Kei-Lai Fong Twitter Account  Kei-Lai Fong News  Kei-Lai Fong on Facebook


Company Investors

  • Morningside Group (Isaac Cheng)

 

 

 

Browse more funded tech companies:

Synchron | Synchronica

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary